A revolutionary artificial intelligence system for data-driven medicine

Swiss company Sophia Genetics, a global leader in data-driven medicine, has unveiled SOPHiA, the world’s most advanced collective artificial intelligence for data-driven medicine. It can predict and diagnose genetic diseases such as cancer. Sophia Genetics has created collective artificial intelligence for data driven medicine called SOPHiA. This state-of-the-art technology predicts variant pathogenicity with 98% accuracy, […]

Swiss company Sophia Genetics, a global leader in data-driven medicine, has unveiled SOPHiA, the world’s most advanced collective artificial intelligence for data-driven medicine. It can predict and diagnose genetic diseases such as cancer.

Sophia Genetics has created collective artificial intelligence for data driven medicine called SOPHiA. This state-of-the-art technology predicts variant pathogenicity with 98% accuracy, and continuously improves its ability to detect and diagnose genomic conditions by analyzing a pool of DNA data sent to the company by 170 hospitals in 28 countries.

“SOPHiA facilitates clinical interpretation and its artificial intelligence features give medical experts more time to focus on the study of complex cases”, Jurgi Camblong, CEO and co-founder of Sophia Genetics, explained in a press release. SOPHiA is expected to allow clinicians to offer faster and better diagnostics, and patients to benefit from better treatments.

Sophia Genetics was founded in 2011 at the École Polytechnique Fédérale de Lausanne (EPFL) Innovation Park. Today it is the only company in the field of genomics with both ISO 13485 (Medical Devices Quality Management) and ISO 27001 (Information Security Management) certifications.